Insider Transactions in Q2 2022 at Core Laboratories N V (CLB)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 01
2022
|
Mark Damian Tattoli SVP, Gen Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
450
+4.8%
|
-
|
|
May 01
2022
|
Mark Damian Tattoli SVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
174
-1.95%
|
$4,524
$26.0 P/Share
|
|
Apr 01
2022
|
Gregory Barry Barnett Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,307
+11.27%
|
-
|
|
Apr 01
2022
|
Martha Z. Carnes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,307
+14.64%
|
-
|
|
Apr 01
2022
|
Harvey Robert Klingensmith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,307
+17.2%
|
-
|
|
Apr 01
2022
|
Michael Straughen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,307
+21.76%
|
-
|
|
Apr 01
2022
|
Michael Straughen Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,982
-12.8%
|
$63,424
$32.43 P/Share
|
|
Apr 01
2022
|
Kwaku Temeng Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,307
+50.0%
|
-
|
|
Apr 01
2022
|
Eeuwijk Monique Van Dijken Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,307
+27.02%
|
-
|